Kiwangwa and Fukayosi clinics
Bagamoyo, Tanzania
NCT Number: NCT05567016
This trial will assess the long-term health and socioeconomic impact of interventions targeting low-density malaria infection (LMI) among children in Tanzania
Looking for future studies?
Notify Me6 month–10 year
All sexes
Interventional
Not applicable
Bagamoyo, Tanzania
This is a 3-arm open-label randomized control trial of 600 children aged 6 months to 10 years in Tanzania, where transmission is low and a high proportion of infections are low-density. Standard of care based on passive case detection (PCD) using rapid diagnostic test (control arm) will be compared to two different approaches to detect and treat P. falciparum LMI: active case detection using molecular testing (ACDm) and PCD using molecular testing (PCDm). Aims are:
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
In the ACDm arm, children will receive ACD using RDT and qPCR 3x yearly with treatment using artemether-lumefantrine (AL) if RDT or qPCR positive. With fevers, participants will receive standard PCD using RDT.
With fevers, participants will receive PCDm, in which qPCR will be done in RDT negatives with treatment using AL if positive.
With fevers, participants will receive standard PCD using RDT with treatment using AL if positive.
Time frame: 24-30 months from enrollment
Number of sick visits to health facility per person time, excluding planned admissions for medical care, elective surgery, and trauma.
Time frame: 24-30 months from enrollment
Proportion of routine Hb measurements that are low (<11 g/dL) or moderate-severe low (<8 g/dL)
Time frame: 24-30 months from enrollment
Prevalence of underweight status will be defined as the percentage of participants with low weight for age z-scores of less than -2. The World Health Organization (WHO) anthropometric indices will be utilized for standards.
Time frame: 24-30 months from enrollment
Prevalence of stunting will be defined as the percentage of participants with low height for age z-scores of less than -2. The World Health Organization (WHO) anthropometric indices will be utilized for standards.
Time frame: 24-30 months from enrollment
Prevalence of wasting will be defined as the percentage of participants with low weight for height z-scores of less than -2. The World Health Organization (WHO) anthropometric indices will be utilized for standards.
Time frame: 24-30 months from enrollment
Prevalence of malnutrition will be defined as the percentage of participants with a z-score of -3 to -2 indicating moderate malnutrition or a z-score of less than -3 indicating severe malnutrition in any of the following: weight for age, height for age, or weight for height.
Time frame: 24-30 months from enrollment
Vomiting immediately or within 30minutes following administration of study drugs and measures of non-adherence.
Time frame: 24-30 months from enrollment
Number of fever episodes (reported fever in the past 48hrs and/or axillary temperature of ≥37.5°C) per person time
Time frame: 24-30 months from enrollment
Number of days with overall symptoms reported as moderate (≥3 on a 5-point scale) per person time
Time frame: 24-30 months from enrollment
New episodes of positive malaria test (with fever or other clinical symptoms) per person time
Time frame: 24-30 months from enrollment
Proportion of fever episodes that lead to clinical failure, defined as persistent or worsening symptoms assessed 7 and 28 days after initial evaluation.
Time frame: 24-30 months from enrollment
Proportion of routine samples with parasites detected by microscopy or quantitative polymerase chain reaction (qPCR).
Time frame: 24-30 months from enrollment
Number of antibiotic regimens prescribed per person time
Time frame: 24-30 months from enrollment
GSED is a validated instrument that measures population-level early childhood development. The tool measures children's early skills and behaviors in four primary domains: motor, cognitive, language, and social-emotional development.Measures will be normalized within our sample to mean 0 and standard deviation 1, with higher scores indicating better test performance.
Time frame: 24-30 months from enrollment
The IDELA is a validated, global tool that uses direct child assessment to measure early learning and development across 4 core domains (Emergent Literacy, Emergent Numeracy, Motor, Social-emotional). Scores range from 0-100% as a percentage of correct tasks averaged across the 4 domains. Measures will be normalized within our sample to mean 0 and standard deviation 1, with higher scores indicating better test performance.
Time frame: 24-30 months from enrollment
The East African Neurodevelopment Assessment Tool is a locally adapted modification of the Kaufman Brief Intelligence Test 2nd Ed. The test assesses 3 core metrics including general intelligence, executive function, literacy skills - in addition to behavioral and emotional development. Measures will be normalized within our sample to mean 0 and standard deviation 1, with higher scores indicating better test performance.
Time frame: 24-30 months from enrollment
The pencil tapping test is one of the tasks in the Preschool Self-Regulation Assessment (PSRA) and is used to assess inhibitory control in younger children. The child and an assessor have pencils, and child is instructed to tap one/two times(s) depending on what assessor does, with the number of correct responses scored. Measures will be normalized within our sample to mean 0 and standard deviation 1, with higher scores indicating better test performance.
Time frame: 24-30 months from enrollment
Code transmission test is a sub-test of Test of Everyday Attention for Children (TEA-Ch) used for assessment of sustained attention in children. In the test, the child must remember spoken digits, and remember the digit that comes before sequence of numbers. Child is scored on completed and correct answers. Measures will be normalized within our sample to mean 0 and standard deviation 1, with higher scores indicating better test performance.
Time frame: 24-30 months from enrollment
The number of days of school absenteeism for any reason including illness.
Time frame: 24-30 months from enrollment
School performance will be defined as the incidence of school advancement to the next grade.
Time frame: 24-30 months from enrollment
Estimated long-term income loss due to impaired early childhood development
Time frame: 24-30 months from enrollment
Total caregiver-reported costs of sick visits and transport to sick visits plus estimated loss of income from number of days of caregiver work absenteeism.
Time frame: 24-30 months from enrollment
Estimated costs of testing and treatment for caregiver-reported number of sick visits.
Time frame: 24-30 months from enrollment
Cost per outcome averted (e.g., per sick visit averted, per disability adjusted life years (DALYs), and per economic dollar saved, etc.)
Time frame: 24-30 months from enrollment
Proportion of sick visits with elevated elevated C-reactive pep-tide (CRP)
Time frame: 24-30 months from enrollment
Percentage of patients with antimalarial antibodies
Time frame: 24-30 months from enrollment
Percentage of patients with elevated cytokines
Time frame: 24-30 months from enrollment
Percentage of patients with vaccine antibodies
Time frame: 24-30 months from enrollment
Percentage of patients with common pathogen antibodies
Time frame: 24-30 months from enrollment
Number of AEs per person time. AEs will be considered as any grade 3-4 AE or serious adverse event (SAE); individual AEs; or AEs related to study drugs.
Time frame: 24-30 months from enrollment
Incidence proportion of wasting will be defined for each age range of measurement. It is defined as the proportion of children not wasted at the start of the period who became wasted during the age period (the proportion of children who had the onset of new episodes during the period). Incident wasting episodes are defined as a change in weight-for-length z-scores from above -2 Z in the prior measurement to below -2 Z in the current measurement. We will define incident severe wasting analogously using a -3 Z cutoff. We will assume a 60-day washout period before a new wasting episode could occur.
Time frame: 24-30 months from enrollment
Incidence proportion of stunting will be defined for each age range of measurement. It is defined as the proportion of children not stunted at the start of the period who became stunted during the age period. Incident stunting episodes will be defined as a change in length-for-age z-scores from above -2 Z in the prior measurement to below -2 Z in the current measurement. We will define incident severe stunting analogously using a -3 Z cutoff.
University of California, San Francisco
Other
Child Health and Infection With Low Density (CHILD) Malaria, a Randomized Controlled Trial to Assess the Long-term Health and Socioeconomic Impact of Interventions Targeting Low-density Malaria Infection (LMI) Among Children in Tanzania
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05978037
Infections, Malaria
Oxford, Oxfordshire, United Kingdom
View Trial DetailsNCT05979207
Anti-Infective Agents, Antimalarials
Brisbane, Queensland, Australia
View Trial DetailsNCT05878366
Infections, Malaria
Ouagadougou, Burkina Faso
View Trial DetailsNCT05287893
Infections, Inflammation
Brisbane, Queensland, Australia
View Trial Details